Aier Eye Hospital Group Co., Ltd.

Aier Eye Hospital Group Co., Ltd. is a national chain of professional ophthalmic medical institutions in China, specializing in the diagnosis and treatment of eye diseases, surgical services, and medical optometry. Established in 2009 and listed on the ChiNext board of the Shenzhen Stock Exchange, Aier Eye Hospital Group has positioned itself as the world's largest ophthalmic chain group, leveraging its brand advantages in medical networks, professional services, and academic research. The company operates under a "Hierarchical Chain" development model tailored to China's national conditions, which includes a network of hospitals and clinics across various city levels. Aier Eye Hospital Group integrates medical treatment, teaching, and scientific research, enhancing its industry status through partnerships with educational institutions and research organizations. It employs competitive talent incentive mechanisms and continuously adopts advanced ophthalmic technologies, ensuring a comprehensive range of medical services that cater to the growing demand for ophthalmic care in China.

1. “Hierarchical Chain” Development Model Suitable for China’s National Conditions The hierarchical chain model of “Central City Hospital - Provincial Capital Hospital - Prefecture-Level Hospital - County-Level Hospital” has been established, as well as intra-city network formed by multiple hospitals in one city, clinics and Aier E-Stations. "Horizontal and vertical networks" are formed in different provinces, which not only achieves a rapid chain effect, but also meets the needs of people at all levels for ophthalmic medical services. 2. Leading Advantage of “Medical Treatment - Teaching – Scientific Research” Integration The industry status and influence of our company are increasingly enhanced with the establishment of Aier School of Ophthalmology, Central South University, Aier Eye Institute, Academician Workstation, etc. 3. Competitive Incentive Mechanism for Talents The Executive Stock Options, Restricted Stock Plans and Partnership Programs have been put into force in our company, encouraging the development of talents. 4. Leading Technology Advantage Our company keeps track of and introduces the up-to-date international ophthalmic diagnosis and treatment technology and advanced equipment, among which a large number of technologies have filled in the gaps in China. We provide multi-level medical services to patients.